Noninvasive assessment of endothelial function and vascular parameters in patients with familial and nonfamilial hypercholesterolemia

Polskie Archiwum Medycyny Wewnetrznej

Volumn 124, Issue 10, 2014, Pages 516-524

  Lewandowski, Paweł ^a   Romanowska Kocejko, Marzena ^a   Węgrzyn, Agnieszka ^a   Chmara, Magdalena ^a   Zuk, Monika ^a   Limon, Janusz ^a   Wasąg, Bartosz ^a   Rynkiewicz, Andrzej ^b   Gruchała, Marcin ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

Author keywords

Arterial stiffness; Atherosclerosis; Endothelial dysfunction; Familial hypercholesterolemia

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTERIAL STIFFNESS; ARTICLE; BRACHIAL ARTERY; CARDIOVASCULAR PARAMETERS; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT; CONTROLLED STUDY; ENDOTHELIUM; FAMILIAL HYPERCHOLESTEROLEMIA; FEMALE; FLOW MEDIATED DILATION; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; NONFAMILIAL HYPERCHOLESTEROLEMIA; PHOTOELECTRIC PLETHYSMOGRAPHY; ULTRASOUND; VASODILATATION; BLOOD; CASE CONTROL STUDY; COMMON CAROTID ARTERY; DIAGNOSTIC IMAGING; HYPERCHOLESTEROLEMIA; MIDDLE AGED; PATHOPHYSIOLOGY; VASCULAR ENDOTHELIUM;

ADULT; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; CHOLESTEROL, LDL; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERLIPOPROTEINEMIA TYPE II; MALE; MIDDLE AGED;

EID: 84908480895     PISSN: 00323772     EISSN: 18979483     Source Type: Journal    
DOI: 10.20452/pamw.2458     Document Type: Article

References (32)

1. Dawber T, Meadors G, Moore F. Epidemiological approaches to heart disease: the Framingham Study. Am J Public Health. 1951;41:279-286.
2. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebo-controlled trial. Lancet. 2002;360:7-22.
3. Chmara M, Wasag B, Zuk M, et al. Molecular characterization of Polish patients with familial hypercholesterolemia: novel and recurrent LDLR mutations. J Appl Genet. 2010;1:95-106.
4. Brown M, Goldstein J. A receptor-mediated pathway for cholesterol homeostasis. Science. 1986;232:34-47.
5. Marais D. Familial hypercholesterolemia. Clin Biochem Rev. 2004;25:49-68.
6. Schmidt R, Beyer T, Bench W, et al. Secreted proprotein convertase subtilisin/kexin type 9 reduces both hepatic and extrahepatic low-density lipoprotein receptors in vivo. Biochem Biophys Res Commun. 2008;13:634-640.
7. Davignon J, Ganz P. Role of endothelial dysfunction in Atherosclerosis. Circulation. 2004;109:III-27-III-32.
8. Corson M, James N, Latta S, et al. Phosphorylation of endothelial nitric oxide synthase in response to fluid shear stress. Circ Res. 1996;79:984-999.
9. Ross R. Atherosclerosis. An inflammatory disease. N Engl J Med. 1999;340:115-128.
10. Dawber T, Kannel WB. The Framinghan study. An epidemiological approach to coronary heart disease. Circulation. 1966;34:553-555.
11. Kozela M, Szafraniec K, Broda G, et al. POLKARD Study Group. Detection and treatment of hypercholesterolemia in primary health care. Results of the POLKARD program of the Ministry of Health of the Republic of Poland. Pol Arch Med Wewn. 2012;122:154-161.
12. Kathiresan S, Larson M, Keyes M, et al. Assessment by cardiovascular magnetic resonance, electron beam computed tomography and carotid ultrasonography of the distribution of subclinical atherosclerosis across Framingham risk strata. Am J Cardiol. 2007;99:310-314.
13. Deanfield J, Donald A, Ferri C, et al. Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part I. Methodological issues for assessment in the different vascular beds: a statement by the Working Group on Endothelin and Endothelial Factors of the European Society of Hypertension. J Hypertens. 2005;23:7-17.
14. Wilk G, Osmenda G, Matusik P, et al. Endothelial function assessment in atherosclerosis. Pol Arch Med Wewn. 2013;123:444-452.
15. Naka K, Tweddel A, Doshi S, et al. Flow-mediated changes in pulse wave velocity: a new clinical measure of endothelial function. Eur Heart J. 2006;27:302-309.
16. Bonetti P, Pumper G, Higano S, et al. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol. 2004;44:2137-2141.
17. Nohria A, Gerhard-Herman M, Creager M, et al. Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. J Appl Physiol. 2006;101:545-548.
18. Donald A, Charakida M, Cole T, et al. Non-invasive assessment of endothelial function: which technique? J Am Coll Cardiol. 2006;48:1846-1850.
19. Brunner H, Cockcroft J, Deanfiled J, et al. Endothelial function and dysfunction. Part II: association with cardiovascular risk factors and disease. A statement by the Working Group on Endothelins and Endothelial factors of The European Society of Hypertension. J Hypertens. 2005;23:233-246.
20. Davies J, Struthers A. Pulse wave analysis and pulse wave velocity: a critical review of their strengths and weaknesses. J Hypertens. 2003;21:463-472.
21. World Health Organization. Familial hypercholesterolemia-report of a second WHO Consultation. Geneva, Switzerland: World Health Organization, 1999. WHO publication no. WHO/HGN/FH/CONS/99.2.
22. Celermajer D, Sorensen K, Gooch V, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet. 1992;340:1111-1115.
23. Halcox J, Schenke W, Zalos G, et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation. 2002;106:653-658.
24. Kullo I, Malik A. Arterial ultranonography and tonometry as adjuncts to cardiovascular risk stratification. J Am Coll Cardiol. 2007;49:1413-1426.
25. Masoura C, Pitsavos C, Aznaouridis K, et al. Arterial endothelial function and wall thickness in familial hypercholesterolemia and familial combined hyperlipidemia and the effects of statins. A systematic review and meta-analysis. Atherosclerosis. 2011;214:129-138.
26. Laurent S, Cockcroft J, Van Bortel L, et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J. 2006;27:2588-2605.
27. Jaroch J, Łoboz-Grudzień K, Kowalska A, et al. e-Tracking of carotid arteries as a new tool in the evaluation of early functional vascular remodeling. Eur J Echocardiogr. 2006;7:119.
28. Jaroch J, Łoboz-Grudzień K, Kowalska A, et al. [Echo tracking and wave intensity - new, noninvasive methods of vascular function assessment]. Pol Przegl Kardio. 2008;10:137-143. Polish.
29. Rynkiewicz A, Cybulska B, Banach M, et al. Management of familial heterozygous hypercholesterolemia. Position paper of the Polish Lipid Expert Forum. Pol Arch Med Wewn. 2013;123:7-10.
30. Mizia-Stec K, Gąsior Z, Zahorska-Markiewicz B, et al. High simvastatin doses in acute coronary syndromes and doppler indices of endothelial function in long-term observation. Folia Cardiol. 2004;11, 6:425-432.
31. Taddei S, Virdis A, Ghiadoni L, et al. Menopause is associated with endothelial dysfunction in women. Hypertension. 1996;28:576-582.
32. Austin M, Hutter C, Zimmern R, Humpries S. Familial Hypercholesterolemia and Coronary Heart Disease: A HuGE Association Review. Am J Epidemiol. 2004;160:421-429.